About Edwards Lifesciences Corp
Ticker
info
EW
Trading on
info
NYSE
ISIN
info
US28176E1082
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Bernard J. Zovighian
Headquarters
info
One Edwards Way, Irvine, CA, United States, 92614
Employees
info
15,800
Website
info
edwards.com
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Metrics
BasicAdvanced
Market cap
info
$40.9B
P/E ratio
info
29.86
EPS
info
$2.34
Dividend Yield
info
0.00%
Beta
info
1.15
Forward P/E ratio
info
28.57
EBIDTA
info
$1.64B
Ex dividend date
info
-
Price & volume
Market cap
info
$40.9B
Average daily volume
info
5.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
29.86
Forward P/E
info
28.57
PEG ratio
info
4.17
Trailing P/E
info
29.86
Price to sales
info
7.52
Price to book
info
4.07
Earnings
EPS
info
$2.34
EPS estimate (current quarter)
info
$0.55
EPS estimate (next quarter)
info
$0.59
EBITDA
info
$1.64B
Revenues (TTM)
info
$5.44B
Revenues per share (TTM)
info
$9.10
Technicals
Beta
info
1.15
52-week High
info
$95.25
52-week Low
info
$58.93
50-day moving average
info
$71.36
200-day moving average
info
$71.65
Short ratio
info
1.99
Short %
info
1.85%
Management effectiveness
ROE (TTM)
info
16.64%
ROA (TTM)
info
8.26%
Profit margin
info
76.75%
Gross profit margin
info
$4.32B
Operating margin
info
25.54%
Growth
Quarterly earnings growth (YoY)
info
7.10%
Quarterly revenue growth (YoY)
info
9.40%
Share stats
Outstanding Shares
info
586M
Float
info
582M
Insiders %
info
0.90%
Institutions %
info
88.74%
Analyst Insights & forecasts
info

43% Buy

57% Hold

0% Sell

Based on information from 33 analysts.

Average price target

info
$80.08
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.66
$0.64
3.13%
Q1 • 24Beat
$0.70
$0.69
1.45%
Q2 • 24Beat
$0.67
$0.64
4.69%
Q3 • 24Beat
$0.59
$0.55
6.38%
Q4 • 24Beat
-
-
-
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.35B
$3.07B
226.73%
Q3 • 24
$1.39B
$386M
27.83%
Q4 • 24
2.32%
87.44%
87.73%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$13B
$3.36B
25.90%
Q3 • 24
$13.1B
$2.99B
22.92%
Q4 • 24
0.65%
10.94%
11.51%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$352M
$2.7B
$-977M
$320M
Q3 • 24
$-128M
$-577M
$28.6M
$-177M
Q4 • 24
136.24%
121.35%
102.93%
155.42%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Edwards Lifesciences Corp share?
Collapse

Edwards Lifesciences Corp shares are currently traded for undefined per share.

How many shares does Edwards Lifesciences Corp have?
Collapse

Edwards Lifesciences Corp currently has 586M shares.

Does Edwards Lifesciences Corp pay dividends?
Collapse

No, Edwards Lifesciences Corp doesn't pay dividends.

What is Edwards Lifesciences Corp 52 week high?
Collapse

Edwards Lifesciences Corp 52 week high is $95.25.

What is Edwards Lifesciences Corp 52 week low?
Collapse

Edwards Lifesciences Corp 52 week low is $58.93.

What is the 200-day moving average of Edwards Lifesciences Corp?
Collapse

Edwards Lifesciences Corp 200-day moving average is $71.65.

Who is Edwards Lifesciences Corp CEO?
Collapse

The CEO of Edwards Lifesciences Corp is Bernard J. Zovighian.

How many employees Edwards Lifesciences Corp has?
Collapse

Edwards Lifesciences Corp has 15,800 employees.

What is the market cap of Edwards Lifesciences Corp?
Collapse

The market cap of Edwards Lifesciences Corp is $40.9B.

What is the P/E of Edwards Lifesciences Corp?
Collapse

The current P/E of Edwards Lifesciences Corp is 29.86.

What is the EPS of Edwards Lifesciences Corp?
Collapse

The EPS of Edwards Lifesciences Corp is $2.34.

What is the PEG Ratio of Edwards Lifesciences Corp?
Collapse

The PEG Ratio of Edwards Lifesciences Corp is 4.17.

What do analysts say about Edwards Lifesciences Corp?
Collapse

According to the analysts Edwards Lifesciences Corp is considered a hold.